Power Law company profile

Zealand Pharma

Biotech & Life Sciences · Søborg, Denmark · Founded 1998 · IPO 2017 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.36B

Market cap · 2026

Revenue

$1.35B

Latest reported FY

Investors

6 investors on Zealand Pharma's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

Heartcore Capital

Eurazeo

Series B+ 4 investors entered at this stage

HBM Healthcare Investments

Sanofi-Genzyme BioVentures

Kurma Partners

Van Herk Investments

Global footprint

Where Zealand Pharma has talent and traffic

AI talent share

0.2% of workforce is AI talent
(1 of 596 staff)

Core AI00%

Other AI10.17%

Non-AI workforce59599.83%

Web traffic by country

30K monthly visits
across markets

🇩🇰 Denmark34.7%

🇺🇸 United States18.7%

🇫🇷 France11%

🏳️ New Zealand8.7%

🇬🇧 United Kingdom6%

Top 5 markets shown

Patent intelligence

$254M patent portfolio · 119 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$254M

18.7% of market cap · 15.7× the top peer Kerecis ($16M)

119 active patent families

Where Zealand Pharma innovates Biomedical engineeringIntensive care medicineSurgeryInjection deviceGeneral surgery

Below peer median on Legal, Strategic

Quality vs same-sector peers

Zealand Pharma on the five Patsnap quality dimensions

Zealand Pharma in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Zealand Pharma concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Zealand Pharma and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Zealand Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo